Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin during inpatient detoxification for crack/cocaine dependence
RBR-7djc66Phase 2Recruiting
- Sponsor
- Secretaria Nacional de Políticas sobre Drogas
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxytocin in cocaine use disorder (CUD) (3 arms), sponsored by Secretaria Nacional de Políticas sobre Drogas. Started Sep 2018; status: recruiting.
02
Drugs
oxytocin
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on RBR-7djc66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7djc66.